Effect of Empathy-Based Program on Nursing Assistants in Long-term Care Facilities
Active, enrolledNAResults postedLast updated 25 February 2026
What this trial tests
NA trial testing Virtual Reality (VR) with Debriefing in Long-Term Care in 103 participants. Participants enrolled and being followed up; not accepting new ones.
20 and older, any sex, with Long-Term Care or Long-term Care Facility. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Attitudes Toward Older PeopleSecondary· Baseline (pre-intervention), end of intervention (week 3), and follow-up at one month post-intervention (week 7)
This study will use the Chinese version of the Kogan's Attitudes toward Older People (KAOP) Scale, translated and validated by Yeh et al. (2009), to assess participants' attitudes toward older adults. The KAOP consists of 34 items, including 17 positively worded and 17 negatively worded statements. Each item is rated on a 7-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). Negatively worded items are reverse-coded before computing the total score. The possible total score ranges from 34 to 238, with higher scores indicating more positive attitudes toward older people
Baseline(T0)
Group
Value
95% CI
Control Group (C)
135.70
± 14.84
Virtual Reality (VR) With Debriefing Group
138.70
± 11.96
End of intervention - week 3(T1)
Group
Value
95% CI
Control Group (C)
140.28
± 16.14
Virtual Reality (VR) With Debriefing Group
144.66
± 16.20
Follow-up - week 7(T2)
Group
Value
95% CI
Control Group (C)
142.06
± 15.90
Virtual Reality (VR) With Debriefing Group
142.00
± 16.74
Empathy LevelPrimary· Baseline (pre-intervention), end of intervention (week 3), and follow-up at one month post-intervention (week 7)
This study will use the 20-item version of the Jefferson Scale of Empathy-Health Professions version (JSE-HP). The scale has 20 items scored on a 7-point Likert scale, ranging from 1 (minimum) to 7 (maximum), with a total score between 20 and 140. Higher scores indicate greater empathy level among nursing assistants.
Baseline (pre-intervention)
Group
Value
95% CI
Control Group (C)
96.66
± 14.29
Virtual Reality (VR) With Debriefing Group
100.83
± 14.00
End of intervention (week 3)
Group
Value
95% CI
Control Group (C)
99.20
± 14.38
Virtual Reality (VR) With Debriefing Group
111.51
± 12.50
Follow-up at one month post-intervention (week 7, T2)
Group
Value
95% CI
Control Group (C)
97.46
± 13.85
Virtual Reality (VR) With Debriefing Group
104.47
± 16.67
Empathic BehaviorSecondary· Baseline (pre-intervention), end of intervention (week 3), and follow-up at one month post-intervention (week 7)
This study will use a 12-item Empathic Behavior Scale developed by the researchers based on a review of relevant literature. The scale is designed to assess the frequency of empathic behaviors performed by nursing assistants in various caregiving scenarios. Each item presents a specific situation, and participants are asked to indicate how frequently they perform the described empathic behavior using a 7-point Likert scale, ranging from 1 (never able to perform) to 7 (always able to perform). Total scores range from 12 to 84, with higher scores indicating more frequent engagement in empathic b
Baseline(T0 )
Group
Value
95% CI
Control Group (C)
66.80
± 8.95
Virtual Reality (VR) With Debriefing Group
65.75
± 10.59
End of intervention (week 3)
Group
Value
95% CI
Control Group (C)
68.44
± 9.46
Virtual Reality (VR) With Debriefing Group
69.81
± 9.05
Follow-up at one month post-intervention (week 7, T2)
Group
Value
95% CI
Control Group (C)
66.32
± 8.91
Virtual Reality (VR) With Debriefing Group
67.02
± 8.80
Sponsor's own description
This randomized controlled trial aims to explore the impact of an Empathy-Based Program on the level of empathy among nursing assistants in a long-term care facility. A total of 100 participants will be divided into two groups: a virtual reality (VR) with debriefing group, and a control group (C) receiving routine care. The intervention involves a weekly 5-minute VR session featuring immersive experiences of residents' lives within the facility, followed by a 25-minute debriefing discussion in small groups of 5\~6 participants. This will continue for three weeks. The study will evaluate the effectiveness of the empathy program in enhancing nursing assistants' empathy levels, with data collection occurring at three time points: baseline, post-intervention, and one-month follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
NCT06736782 — Holistic Self-Empowerment Care Intervention for Optimized Independent Living and Quality of Life: A Study Protocol
· NA
· recruiting
NCT06239688 — Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
· NA
· recruiting
NCT06536322 — Evaluation of the Use of a Novel Oral Health Screening Instrument by Caregivers in Nursing Homes
· NA
· active not recruiting
Other Taipei Medical University trials
Trials by the same sponsor.
NCT07496658 — Nutritional Status, Nutritional Knowledge and Mental Health Among Indonesian Migrant Workers in Taiwan
· not yet recruiting
NCT06930313 — Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC)
· NA
· not yet recruiting
NCT07349446 — Effects of Circadian-Based Acupressure on Sleep Quality in Nursing Home Residents
· NA
· not yet recruiting
NCT07259369 — The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients
· NA
· not yet recruiting
NCT07275372 — Using Virtual Humans to Teach Cognitive Function Assessment to Nursing Students
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University
Last refreshed: 25 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07044492.